IQ Global Equity R&D Leaders ETF (WRND US) – Investment Proposition

IQ Global Equity R&D Leaders ETF (WRND) presents a systematic way to access companies that prioritize research and development, capturing firms whose business models emphasize innovation, product pipelines, and intellectual-property advantages. The strategy tracks a rules-based global selection of large- and mid-cap equities with elevated R&D intensity, resulting in meaningful exposure to technology, healthcare, and select industrials while remaining diversified across issuers and regions. Return potential is tied to sustained innovation cycles, commercialization of new platforms, and durable competitive moats; income is typically modest. Style tilts often skew toward growth and quality, with sensitivity to interest-rate moves that affect long-duration cash flows, as well as to market phases that reward or penalize high-multiple franchises. In portfolios, WRND can serve as a growth-oriented satellite, a factor-completion sleeve targeting innovation risk premia, or a mandate for thematic allocators emphasizing intangible-capital leaders. Suitable users include long-horizon investors seeking secular growth exposure and multi-asset teams balancing core holdings with targeted innovation. A key risk to monitor is concentration in innovation-heavy industries, which can elevate volatility and increase reliance on accounting definitions and reported R&D metrics.

To explore WRND in more depth, visit our ETF analytics platform for institutional-grade insights — including performance and risk metrics, correlations, sensitivities, and factor exposure: https://www.etfstrategy.com/etf/WRND_US